Early Administration of Anti-SARS-CoV-2 Monoclonal Antibodies Prevents Severe COVID-19 in Kidney Transplant Patients
Kidney Int Rep
.
2022 Oct;7(10):2319-2320.
doi: 10.1016/j.ekir.2022.08.014.
Epub 2022 Aug 30.
Authors
Juliette Gueguen
1
,
Philippe Gatault
2
Affiliations
1
Service Néphrologie, Hypertension Artérielle, Dialyses et Transplantation Rénale, Tours Laboratoire T2I (Transplantation, Immunologie, Inflammation), France.
2
Hôpital Bretonneau, Tours, France.
PMID:
36060622
PMCID:
PMC9423876
DOI:
10.1016/j.ekir.2022.08.014
No abstract available